denotes an abstract that is clinically relevant.
denotes that this is a recommended PHD Trainee Session.
denotes that this is a ticketed session.
Program: Scientific Program
Session: Paradigm Shifts in Hemostasis: From Mechanisms to Therapies and Back
Hematology Disease Topics & Pathways:
Bleeding and Clotting, Clinical Practice (Health Services and Quality), Hemophilia, Diseases, Treatment Considerations, Biological Processes, Technology and Procedures, Pathogenesis, Imaging
Session: Paradigm Shifts in Hemostasis: From Mechanisms to Therapies and Back
Hematology Disease Topics & Pathways:
Bleeding and Clotting, Clinical Practice (Health Services and Quality), Hemophilia, Diseases, Treatment Considerations, Biological Processes, Technology and Procedures, Pathogenesis, Imaging
Sunday, December 8, 2024, 4:30 PM-5:45 PM
Disclosures: von Drygalski: Takeda: Consultancy, Honoraria; Sparx Therapeutics: Consultancy, Honoraria; Novo Nordisk: Consultancy, Honoraria; CSL-Behring: Consultancy, Honoraria; Bioverativ/Sanofi: Consultancy, Research Funding; Pfizer: Consultancy, Research Funding; Genentech: Consultancy, Honoraria; Hematherix LLC: Other: Co-founder; Regeneron: Consultancy, Honoraria; Biomarin: Consultancy, Honoraria.
See more of: Paradigm Shifts in Hemostasis: From Mechanisms to Therapies and Back
See more of: Scientific Program
See more of: Scientific Program
Previous Presentation
|
Next Presentation >>